+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunotherapy Drugs Market (2025 Edition): Analysis By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type, By Region, By Country: Market Insights and Forecast (2020-2030)- Product Image
Immunotherapy Drugs Market (2025 Edition): Analysis By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type, By Region, By Country: Market Insights and Forecast (2020-2030)- Product Image
New

Immunotherapy Drugs Market (2025 Edition): Analysis By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type, By Region, By Country: Market Insights and Forecast (2020-2030)

  • PDF Icon

    Report

  • 209 Pages
  • February 2025
  • Region: Global
  • Azoth Analytics
  • ID: 6050437
Description Jump to:
This report provides an analysis of the Global Immunotherapy Drugs industry in terms of market segmentation By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccines) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The Global Immunotherapy Drugs market showcased growth at a CAGR of 9.27% during 2020-2023. The market was valued at USD 756.92 Billion in 2023 which is expected to reach USD 1.57 trillion in 2030.

The global immunotherapy drugs market is experiencing significant growth, driven by advancements in biotechnology and rising demand for targeted therapies. Immunotherapy has emerged as a transformative treatment modality, leveraging the body's immune system to combat diseases, particularly cancer, autoimmune disorders, and infectious diseases.

Key factors contributing to market expansion include increasing cancer prevalence, a growing pipeline of innovative immunotherapeutic drugs, and the rising adoption of monoclonal antibodies and immune checkpoint inhibitors. Additionally, the shift towards personalized medicine and the development of combination therapies have further bolstered the market's trajectory.

The escalating global burden of chronic diseases, coupled with heightened awareness about immunotherapy, has led to increased adoption among patients and healthcare providers. Governments and private entities worldwide are also investing heavily in research and development (R&D) to accelerate the approval of novel immunotherapies.

Scope of the Report

  • The report analyses the Immunotherapy Drugs Market by Value (USD Billion).
  • The report analyses the Immunotherapy Drugs Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
  • The report presents the analysis of Immunotherapy Drugs Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report analyses the Immunotherapy Drugs Market By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications)
  • The report analyses the Immunotherapy Drugs Market By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccines).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Indication, By Route of Administration and By Drug Type.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analyzed in the report include F. Hoffmann-La Roche AG, Merck & Co., Inc., Eli Lily & Co., Pfizer, Novartis AG, Amgen Inc., Sanofi, Johnson & Johnson, Bayer, Bristol Myers Squibb

Table of Contents

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Adoption of AI in Drug Discovery
2.2 Combination Therapies
3. Global Immunotherapy Drugs Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Immunotherapy Drugs Market
3.2 Prevalence of Cancer, WHO regions
3.3 Global autoimmune disorders spending from 2020 to 2023
3.4 Global Immunotherapy Drugs Market: Dashboard
3.5 Global Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
3.6 Global Immunotherapy Drugs Market: Market Value Assessment
3.7 Global Immunotherapy Drugs Market Segmentation: By Indication
3.7.1 Global Immunotherapy Drugs Market, By Indication Overview
3.7.2 Global Immunotherapy Drugs Market Attractiveness Index, By Indication
3.7.3 Global Immunotherapy Drugs Market Size, By Cancer, By Value, 2020H-2030F (USD Billion & CAGR)
3.7.4 Global Immunotherapy Drugs Market Size, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billion & CAGR)
3.7.5 Global Immunotherapy Drugs Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
3.8 Global Immunotherapy Drugs Market Segmentation: By Drug Type
3.8.1 Global Immunotherapy Drugs Market, By Drug Type Overview
3.8.2 Global Immunotherapy Drugs Market Attractiveness Index, By Drug Type
3.8.3 Global Immunotherapy Drugs Market Size, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billion & CAGR)
3.8.4 Global Immunotherapy Drugs Market Size, By Immunomodulators, By Value, 2020H-2030F (USD Billion & CAGR)
3.8.5 Global Immunotherapy Drugs Market Size, By Vaccines, By Value, 2020H-2030F (USD Billion & CAGR)
4. Immunotherapy Drugs Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Immunotherapy Drugs Market: Historic and Forecast
5.1 Americas Immunotherapy Drugs Market: Snapshot
5.2 Americas Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.3 Americas Immunotherapy Drugs Market: Key Factors
5.4 Americas Immunotherapy Drugs Market: Segment Analysis
5.5 Americas Immunotherapy Drugs Market Segmentation: By Indication
5.5.1 Americas Immunotherapy Drugs Market, By Indication Overview
5.5.2 Americas Immunotherapy Drugs Market Size, By Cancer, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.3 Americas Immunotherapy Drugs Market Size, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.4 Americas Immunotherapy Drugs Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
5.6 Americas Immunotherapy Drugs Market Segmentation: By Drug Type
5.6.1 Americas Immunotherapy Drugs Market, By Drug Type Overview
5.6.2 Americas Immunotherapy Drugs Market Size, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.3 Americas Immunotherapy Drugs Market Size, By Immunomodulators, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.4 Americas Immunotherapy Drugs Market Size, By Vaccines, By Value, 2020H-2030F (USD Billion & CAGR)
5.7 Americas Immunotherapy Drugs Market Segmentation: By Country
5.7.1 Americas Immunotherapy Drugs Market, by Country Overview
5.7.2 United States Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.7.2.1 United States Immunotherapy Drugs Market, By Indication
5.7.2.2 United States Immunotherapy Drugs Market, By Drug Type
5.7.3 Canada Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.7.3.1 Canada Immunotherapy Drugs Market, By Indication
5.7.3.2 Canada Immunotherapy Drugs Market, By Drug Type
5.7.4 Rest of Americas Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.7.5.1 Rest of Americas Immunotherapy Drugs Market, By Indication
5.7.5.2 Rest of Americas Immunotherapy Drugs Market, By Drug Type
6. Europe Immunotherapy Drugs Market: Historic and Forecast
6.1 Europe Immunotherapy Drugs Market: Snapshot
6.2 Europe Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.3 Europe Immunotherapy Drugs Market: Key Factors
6.4 Europe Immunotherapy Drugs Market: Segment Analysis
6.5 Europe Immunotherapy Drugs Market Segmentation: By Indication
6.5.1 Europe Immunotherapy Drugs Market, By Indication Overview
6.5.2 Europe Immunotherapy Drugs Market Size, By Cancer, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.3 Europe Immunotherapy Drugs Market Size, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.4 Europe Immunotherapy Drugs Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
6.6 Europe Immunotherapy Drugs Market Segmentation: By Drug Type
6.6.1 Europe Immunotherapy Drugs Market, By Drug Type Overview
6.6.2 Europe Immunotherapy Drugs Market Size, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Immunotherapy Drugs Market Size, By Immunomodulators, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.4 Europe Immunotherapy Drugs Market Size, By Vaccines, By Value, 2020H-2030F (USD Billion & CAGR)
6.7 Europe Immunotherapy Drugs Market Segmentation: By Country
6.7.1 Europe Immunotherapy Drugs Market, by Country Overview
6.7.2 United Kingdom Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.2.1 United Kingdom Immunotherapy Drugs Market, By Indication
6.7.2.2 United Kingdom Immunotherapy Drugs Market, By Drug Type
6.7.3 Germany Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.3.1 Germany Immunotherapy Drugs Market, By Indication
6.7.3.2 Germany Immunotherapy Drugs Market, By Drug Type
6.7.4 France Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.4.1 France Immunotherapy Drugs Market, By Indication
6.7.4.2 France Immunotherapy Drugs Market, By Drug Type
6.7.5 Italy Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.5.1 Italy Immunotherapy Drugs Market, By Indication
6.7.5.2 Italy Immunotherapy Drugs Market, By Drug Type
6.7.6 Spain Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.6.1 Spain Immunotherapy Drugs Market, By Indication
6.7.6.2 Spain Immunotherapy Drugs Market, By Drug Type
6.7.6 Rest of Europe Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.7.6.1 Rest of Europe Immunotherapy Drugs Market, By Indication
6.7.6.2 Rest of Europe Immunotherapy Drugs Market, By Drug Type
7. Asia Pacific Immunotherapy Drugs Market: Historic and Forecast
7.1 Asia Pacific Immunotherapy Drugs Market: Snapshot
7.2 Asia Pacific Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.3 Asia Pacific Immunotherapy Drugs Market: Key Factors
7.4 Asia Pacific Immunotherapy Drugs Market: Segment Analysis
7.5 Asia Pacific Immunotherapy Drugs Market Segmentation: By Indication
7.5.1 Asia Pacific Immunotherapy Drugs Market, By Indication Overview
7.5.2 Asia Pacific Immunotherapy Drugs Market Size, By Cancer, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.3 Asia Pacific Immunotherapy Drugs Market Size, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.4 Asia Pacific Immunotherapy Drugs Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
7.6 Asia Pacific Immunotherapy Drugs Market Segmentation: By Drug Type
7.6.1 Asia Pacific Immunotherapy Drugs Market, By Drug Type Overview
7.6.2 Asia Pacific Immunotherapy Drugs Market Size, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific Immunotherapy Drugs Market Size, By Immunomodulators, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.4 Asia Pacific Immunotherapy Drugs Market Size, By Vaccines, By Value, 2020H-2030F (USD Billion & CAGR)
7.7 Asia Pacific Immunotherapy Drugs Market Segmentation: By Country
7.7.1 Asia Pacific Immunotherapy Drugs Market, by Country Overview
7.7.2 China Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.2.1 China Immunotherapy Drugs Market, By Indication
7.7.2.2 China Immunotherapy Drugs Market, By Drug Type
7.7.3 Japan Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.3.1 Japan Immunotherapy Drugs Market, By Indication
7.7.3.2 Japan Immunotherapy Drugs Market, By Drug Type
7.7.4 India Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.4.1 India Immunotherapy Drugs Market, By Indication
7.7.4.2 India Immunotherapy Drugs Market, By Drug Type
7.7.5 Rest of Asia Pacific Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.7.5.1 Rest of Asia Pacific Immunotherapy Drugs Market, By Indication
7.7.5.2 Rest of Asia Pacific Immunotherapy Drugs Market, By Drug Type
8. Middle East & Africa Immunotherapy Drugs Market: Historic and Forecast
8.1 Middle East & Africa Immunotherapy Drugs Market: Snapshot
8.2 Middle East & Africa Immunotherapy Drugs Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.3 Middle East & Africa Immunotherapy Drugs Market: Key Factors
8.4 Middle East and Africa Immunotherapy Drugs Market: Segment Analysis
8.5 Middle East & Africa Immunotherapy Drugs Market Segmentation: By Indication
8.5.1 Middle East & Africa Immunotherapy Drugs Market, By Indication Overview
8.5.2 Middle East & Africa Immunotherapy Drugs Market Size, By Cancer, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.3 Middle East & Africa Immunotherapy Drugs Market Size, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.4 Middle East & Africa Immunotherapy Drugs Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
8.6 Middle East & Africa Immunotherapy Drugs Market Segmentation: By Drug Type
8.6.1 Middle East & Africa Immunotherapy Drugs Market, By Drug Type Overview
8.6.2 Middle East & Africa Immunotherapy Drugs Market Size, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East & Africa Immunotherapy Drugs Market Size, By Immunomodulators, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.4 Middle East & Africa Immunotherapy Drugs Market Size, By Vaccines, By Value, 2020H-2030F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Immunotherapy Drugs Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Immunotherapy Drugs Market
11.4 Company Profiles
11.4.1 F. Hoffmann-La Roche AG
11.4.2 Merck & Co., Inc.
11.4.3 Eli Lily & Co.
11.4.4 Pfizer
11.4.5 Novartis AG
11.4.6 Amgen Inc.
11.4.7 Sanofi
11.4.8 Johnson & Johnson
11.4.9 Bayer
11.4.10 Bristol Myers Squibb
12. About the Publisher & Disclaimer
List of Figures
Figure 1: Prevalence of Cancer, WHO regions, 2021
Figure 2: Global autoimmune disorders spending from 2020 to 2023, (in billion U.S. dollars)
Figure 3: Global Immunotherapy Drugs Market Size, By Value, 2020-2023 (USD Billion)
Figure 4: Global Immunotherapy Drugs Market Size, By Value, 2024-2030 (USD Billion)
Figure 5: Global Immunotherapy Drugs Market Share, By Drug Type, 2023 (%)
Figure 6: Market Attractiveness Analysis of Global Immunotherapy Drugs Market, By Indication (2024-2030)
Figure 7: Global Immunotherapy Drugs Market Size, By Cancer, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 8: Global Immunotherapy Drugs Market Absolute Opportunity, By Cancer, 2020-2030 (USD Billion)
Figure 9: Global Immunotherapy Drugs Market Size, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 10: Global Immunotherapy Drugs Market Absolute Opportunity, By Autoimmune & Inflammatory Diseases, 2020-2030 (USD Billion)
Figure 11: Global Immunotherapy Drugs Market Size, By Other Indications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 12: Global Immunotherapy Drugs Market Absolute Opportunity, By Other Indications, 2020-2030 (USD Billion)
Figure 13: Market Attractiveness Analysis of Global Immunotherapy Drugs Market, By Drug Type (2024-2030)
Figure 14: Global Immunotherapy Drugs Market Size, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 15: Global Immunotherapy Drugs Market Absolute Opportunity, By Monoclonal Antibodies, 2020-2030 (USD Billion)
Figure 16: Global Immunotherapy Drugs Market Size, By Immunomodulators, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 17: Global Immunotherapy Drugs Market Absolute Opportunity, By Immunomodulators, 2020-2030 (USD Billion)
Figure 18: Global Immunotherapy Drugs Market Size, By Vaccines, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 19: Global Immunotherapy Drugs Market Absolute Opportunity, By Vaccines, 2020-2030 (USD Billion)
Figure 20: Americas Immunotherapy Drugs Market Size, By Value, 2020H-2030F (USD Billion)
Figure 21: Americas Immunotherapy Drugs Market Share, By Drug Type, 2023 (%)
Figure 22: Americas Immunotherapy Drugs Market, By Cancer, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 23: Americas Immunotherapy Drugs Market, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 24: Americas Immunotherapy Drugs Market, By Other Indications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 25: Americas Immunotherapy Drugs Market, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 26: Americas Immunotherapy Drugs Market, By Immunomodulators, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 27: Americas Immunotherapy Drugs Market, By Vaccines, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 28: United States Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 29: United States Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 30: United States Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 31: United States Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 32: Canada Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 33: Canada Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 34: Canada Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 35: Canada Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 36: Rest of Americas Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 37: Rest of Americas Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 38: Rest of Americas Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 39: Rest of Americas Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 40: Europe Immunotherapy Drugs Market Size, By Value, 2020H-2030F (USD Billion)
Figure 41: Europe Immunotherapy Drugs Market Share, By Drug Type, 2023 (%)
Figure 42: Europe Immunotherapy Drugs Market, By Cancer, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 43: Europe Immunotherapy Drugs Market, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 44: Europe Immunotherapy Drugs Market, By Other Indications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 45: Europe Immunotherapy Drugs Market, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 46: Europe Immunotherapy Drugs Market, By Immunomodulators, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 47: Europe Immunotherapy Drugs Market, By Vaccines, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 48: United Kingdom Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 49: United Kingdom Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 50: United Kingdom Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 51: United Kingdom Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 52: Germany Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 53: Germany Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 54: Germany Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 55: Germany Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 56: France Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 57: France Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 58: France Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 59: France Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 60: Italy Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 61: Italy Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 62: Italy Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 63: Italy Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 64: Spain Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 65: Spain Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 66: Spain Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 67: Spain Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 68: Rest of Europe Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 69: Rest of Europe Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 70: Rest of Europe Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 71: Rest of Europe Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 72: Asia Pacific Immunotherapy Drugs Market Size, By Value, 2020H-2030F (USD Billion)
Figure 73: Asia Pacific Immunotherapy Drugs Market Share, By Drug Type, 2023 (%)
Figure 74: Asia Pacific Immunotherapy Drugs Market, By Cancer, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 75: Asia Pacific Immunotherapy Drugs Market, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 76: Asia Pacific Immunotherapy Drugs Market, By Other Indications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 77: Asia Pacific Immunotherapy Drugs Market, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 78: Asia Pacific Immunotherapy Drugs Market, By Immunomodulators, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 79: Asia Pacific Immunotherapy Drugs Market, By Vaccines, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 80: China Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 81: China Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 82: China Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 83: China Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 84: Japan Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 85: Japan Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 86: Japan Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 87: Japan Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 88: India Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 89: India Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 90: India Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 91: India Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 92: Rest of Asia Pacific Immunotherapy Drugs Market, By Value, 2020-2030 (USD Billions & CAGR)
Figure 93: Rest of Asia Pacific Immunotherapy Drugs Market Value, By Drug Type, 2023 (USD Billion)
Figure 94: Rest of Asia Pacific Immunotherapy Drugs Market Share, By Indication, By Value, 2023 (%)
Figure 95: Rest of Asia Pacific Immunotherapy Drugs Market Share, By Drug Type, By Value, 2023 (%)
Figure 96: Middle East and Africa Immunotherapy Drugs Market Size, By Value, 2020H-2030F (USD Billion)
Figure 97: Middle East and Africa Immunotherapy Drugs Market Share, By Drug Type, 2023 (%)
Figure 98: Middle East and Africa Immunotherapy Drugs Market, By Cancer, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 99: Middle East and Africa Immunotherapy Drugs Market, By Autoimmune & Inflammatory Diseases, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 100: Middle East and Africa Immunotherapy Drugs Market, By Other Indications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 101: Middle East and Africa Immunotherapy Drugs Market, By Monoclonal Antibodies, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 102: Middle East and Africa Immunotherapy Drugs Market, By Immunomodulators, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 103: Middle East and Africa Immunotherapy Drugs Market, By Vaccines, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 104: Market Share of Prominent Companies of Immunotherapy Drugs Market, 2023 (%)
Figure 105: Roche Revenues, 2021-2023 (USD Million)
Figure 106: Roche Revenue , By Sales Division, 2023 (%)
Figure 107: Roche Revenue , By Geographical Segment, 2023 (%)
Figure 108: Merck & Co., Inc. Revenues, 2021-2023 (USD Million)
Figure 109: Merck & Co., Inc. Revenues, By Geographic Segments, 2023 (%)
Figure 110: Merck & Co., Inc. Revenue , By Business Segments, 2023 (%)
Figure 111: Eli Lily & Co. Revenues, 2021-2023 (USD Million)
Figure 112: Eli Lily & Co. Revenues, By Geographic Segments, 2023 (%)
Figure 113: Eli Lily & Co. Revenue , By Business Segments, 2023 (%)
Figure 114: Pfizer Revenues, 2021-2023 (USD Million)
Figure 115: Pfizer Revenues, By Business Segments, 2023 (%)
Figure 116: Pfizer Inc. Revenue , By Geographical Segments, 2023 (%)
Figure 117: Novartis Revenues, 2021-2023 (USD Million)
Figure 118: Novartis Revenues, By Geographic Segments, 2023 (%)
Figure 119: Novartis Revenue , By Business Segments, 2023 (%)
Figure 120: Amgen Revenues, 2021-2023 (USD Million)
Figure 121: Amgen Revenues, By Geographic Segments, 2023 (%)
Figure 122: Amgen Revenue , By Business Segments, 2023 (%)
Figure 123: Sanofi Revenues, 2020-2022 (USD Million)
Figure 124: Sanofi Revenues, By Geographic Segments, 2022 (%)
Figure 125: Sanofi Revenue , By Business Segments, 2022 (%)
Figure 126: Johnson & Johnson Revenue, 2021-2023 (USD Million)
Figure 127: Johnson & Johnson Revenue, By Geographical Segments, 2023 (%)
Figure 128: Johnson & Johnson Revenue, By Business Segments, 2023 (%)
Figure 129: Bayer AG Revenues 2021-2023 (USD Million)
Figure 130: Bayer AG Revenues, By Geographic Segments, 2023 (%)
Figure 131: Bayer AG Revenues, By Business Segments, 2023 (%)
Figure 132: Bristol Myers Squibb Revenues, 2021-2023 (USD Million)
Figure 133: Bristol Myers Squibb Revenues, By Geographic Segments, 2023 (%)
Figure 134: Bristol Myers Squibb Revenue , By Products, 2023 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A3: United States Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A4: United States Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A5: United States Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A6: Canada Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A7: Canada Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A8: Canada Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A9: Canada Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A10: Rest of Americas Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A11: Rest of Americas Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A12: Rest of Americas Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A13: Rest of Americas Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A14: United Kingdom Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A15: United Kingdom Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A16: United Kingdom Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A17: United Kingdom Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A18: Germany Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A19: Germany Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A20: Germany Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A21: Germany Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A22: France Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A23: France Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A24: France Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A25: France Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A26: Italy Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A27: Italy Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A28: Italy Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A29: Italy Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A30: Spain Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A31: Spain Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A32: Spain Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A33: Spain Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A34: Rest of Europe Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A35: Rest of Europe Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A36: Rest of Europe Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A37: Rest of Europe Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A38: China Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A39: China Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A40: China Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A41: China Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A42: Japan Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A43: Japan Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A44: Japan Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A45: Japan Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A46: India Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A47: India Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A48: India Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A49: India Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A50: Rest of Asia Pacific Immunotherapy Drugs Market, By Indication, By Value, 2020-2023 (USD Billion)
Table A51: Rest of Asia Pacific Immunotherapy Drugs Market, By Indication, By Value, 2024-2030 (USD Billion)
Table A52: Rest of Asia Pacific Immunotherapy Drugs Market, By Drug Type, By Value, 2020-2023 (USD Billion)
Table A53: Rest of Asia Pacific Immunotherapy Drugs Market, By Drug Type, By Value, 2024-2030 (USD Billion)
Table A54: Roche Key Financials, 2021-2023
Table A55: Merck & Co., Inc. Key Financials, 2021-2023
Table A56: Eli Lily & Co. Key Financials, 2021-2023
Table A57: Pfizer Key Financials, 2021-2023
Table A58: Novartis Key Financials, 2021-2023
Table A59: Amgen Key Financials, 2021-2023
Table A60: Sanofi Key Financials, 2020-2022
Table A61: Johnson & Johnson Key Company Financials, 2021-2023
Table A62: Bayer AG Key Financials, 2021-2023
Table A63: Bristol Myers Squibb Key Financials, 2021-2023

Companies Mentioned

  • F. Hoffmann-La Roche AG
  • Merck & Co., Inc.
  • Eli Lily & Co.
  • Pfizer
  • Novartis AG
  • Amgen Inc.
  • Sanofi
  • Johnson & Johnson
  • Bayer
  • Bristol Myers Squibb

Related Topics

Related Reports

Cancer Immunotherapy Drugs Market by Type, Indication, End-user - Global Forecast 2025-2030 - Product Image

Cancer Immunotherapy Drugs Market by Type, Indication, End-user - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Immunotherapy Drugs Market Size, Share & Trends Analysis Report By Drug Type, By Indication, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Immunotherapy Drugs Market Size, Share & Trends Analysis Report By Drug Type, By Indication, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Neuroendocrine Tumors (NETs) Market (2024 Edition): Analysis By Therapy (Somatostatin Analogs (SSAs), Targeted Therapy, Others), By Route of Administration, By Indication, By End User, By Region: Market Insights and Forecast (2020-2030) - Product Image

Neuroendocrine Tumors (NETs) Market (2024 Edition): Analysis By Therapy (Somatostatin Analogs (SSAs), Targeted Therapy, Others), By Route of Administration, By Indication, By End User, By Region: Market Insights and Forecast (2020-2030)

  • Report
  • 300 Pages
  • Global
From
Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Forecast to 2029 - Product Image

Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Forecast to 2029

  • Report
  • 335 Pages
  • Global
From
Immunotherapy Drugs Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Type, Application, and End-user - Product Image

Immunotherapy Drugs Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Type, Application, and End-user

  • Report
  • 118 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.